Healthtech is rapidly reshaping how we access, develop, deliver, and manage care. Inga is passionate about partnering with companies that are driving this transformation — especially those harnessing data to unlock new possibilities in Life Sciences and Health.

Inga brings hands-on investment experience in life sciences and digital health, working with ventures spun out of leading UK universities. Her career has also included time in the US, where she gained international industry and healthcare expertise as Chief of Staff at a commercial-stage genetic molecular diagnostics company, and as Entrepreneur in Residence at Duke University.

Her scientific foundation includes a DPhil and MSc in Neuroscience from the University of Oxford, complemented by a BA from the University of Cambridge. This blend of academic rigor and industry insight fuels her enthusiasm for supporting innovators who are advancing the future of healthcare. Watch Inga present at our Investor Day event on Healthtech below.

Watch the video

Connections

Find out more about Inga in our Team Spotlight Blog.

Molten Ventures Growth Fund First Close

Molten Ventures announces the first close of our Growth Fund at £175 million, including a £75 million cornerstone commitment from the British Business Bank. 

“There is no shortage of exceptional founders or technology businesses in the UK and Europe; what they too often lack is sufficient growth capital to help them become global leaders. This Fund gives Molten greater firepower to back our highest-conviction companies at Series B and beyond, build meaningful ownership positions and channel capital into the next generation of growth.” - 
Ben Wilkinson, CEO of Molten
Read the press release here